An Expanding Portfolio of Novel Medical Products
In addition to our UltraClear™ facial rejuvenation technology, Acclaro is developing a portfolio of products that leverage our innovative fiber laser and radio frequency (RF) technologies.
Acclaro is partnering with one of the leading pharmaceutical companies to develop a revolutionary glaucoma treatment platform powered by our MIRACL™ Mid IR Fiber Laser technology. The platform will offer extreme precision, safety, and flexibility with maximum efficacy.
Acclaro is developing an RF-based body contouring and fat destruction platform with strong IP protection. The platform uses a 200-watt smart RF generator and will enable far more efficient and safer treatment than current treatment options in the marketplace.
Our MIRACL™ Mid IR Fiber Laser technology enables precise and controllable cutting, ablating and coagulating of human tissue, which has a wide range of potential applications in minimally invasive endoscopic and robotic surgeries—from removing vocal cord tumors to removing ovarian cancer cysts.